MGC Pharmaceuticals Limited NPV (DI) (MXC) Share Price

Health Care Sector


NOTE: This is based on 9 open tips for MGC Pharmaceuticals Limited NPV (DI) (MXC)


MGC Pharmaceuticals Limited NPV (DI) (MXC)
Latest Quote Price

22.00p

MGC Pharmaceuticals Limited NPV (DI) (MXC)
Price Change (%)

-1.52%


Latest Bid : 21.00p Latest Ask : 23.00p
High Today : 22.90p Low Today : 21.10p
This Years High : 550.00p This Years Low : 18.00p
Volume : 3,655 MKT Cap : £722.92M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

MGC Pharmaceuticals Limited NPV (DI) (MXC) Overview

MGC Pharmaceuticals Limited is a bio-pharma company with a "Nature to Medicine" strategy within the international phytocannabinoid and plant-derived medicines industry. With operations through its subsidiaries in Australia, the European Union and the UK (the "Group"), the Company is developing phytocannabinoid-derived and plant-derived medicines as well as unique formulations, both proprietary and for third parties, all to GMP standard.

MGC Pharmaceuticals Limited NPV (DI) (MXC) Latest Tips

Type Tipster SectorScore Start date Performance
Speculative Buy Canaccord Genuity Premium Only 2023-03-22 13:31:00 22/03/2023 -96.00%
Sell Tom Winnifrith Premium Only 2023-02-03 10:55:00 03/02/2023 96.00%
Sell Tom Winnifrith Premium Only 2022-09-04 17:10:00 04/09/2022 97.85%
Sell Tom Winnifrith Premium Only 2022-07-08 12:00:00 08/07/2022 97.54%
Sell Tom Winnifrith Premium Only 2022-06-16 16:00:00 16/06/2022 97.80%

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


MGC Pharmaceuticals Limited NPV (DI) (MXC) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 21.00p Latest Ask : 23.00p
High Today : 22.90p Low Today : 21.10p
This Years High : 550.00p This Years Low : 18.00p
Volume : 3,655 MKT Cap : £722.92M

MGC Pharmaceuticals Limited NPV (DI) Overview

MGC Pharmaceuticals Limited is a bio-pharma company with a "Nature to Medicine" strategy within the international phytocannabinoid and plant-derived medicines industry. With operations through its subsidiaries in Australia, the European Union and the UK (the "Group"), the Company is developing phytocannabinoid-derived and plant-derived medicines as well as unique formulations, both proprietary and for third parties, all to GMP standard.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest MGC Pharmaceuticals Limited NPV (DI) Tips

Type Tipster SectorScore Start date Performance
Speculative Buy Canaccord Genuity Premium Only 2023-03-22 13:31:00 22/03/2023 -96.00%
Sell Tom Winnifrith Premium Only 2023-02-03 10:55:00 03/02/2023 96.00%
Sell Tom Winnifrith Premium Only 2022-09-04 17:10:00 04/09/2022 97.85%
Sell Tom Winnifrith Premium Only 2022-07-08 12:00:00 08/07/2022 97.54%
Sell Tom Winnifrith Premium Only 2022-06-16 16:00:00 16/06/2022 97.80%